Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common stock, par value $0.001 per share
-
Shares outstanding
-
5.43M
-
Number of holders
-
60
-
Total 13F shares, excl. options
-
9.45M
-
Shares change
-
-6.86M
-
Total reported value, excl. options
-
$46.5M
-
Value change
-
-$98.1M
-
Number of buys
-
37
-
Number of sells
-
-29
-
Price
-
$4.92
Significant Holders of Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE) as of Q4 2020
74 filings reported holding APRE - Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share as of Q4 2020.
Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE) has 60 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.45M shares
.
Largest 10 shareholders include Versant Venture Management, LLC (1.43M shares), 5AM Venture Management, LLC (1.38M shares), Redmile Group, LLC (1.27M shares), FMR LLC (1.26M shares), VANGUARD GROUP INC (750K shares), Artisan Partners Limited Partnership (518K shares), MORGAN STANLEY (473K shares), Candriam Luxembourg S.C.A. (362K shares), CAAS CAPITAL MANAGEMENT LP (184K shares), and Sectoral Asset Management Inc (164K shares).
This table shows the top 60 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.